伟思医疗：股东志达创投减持公司股份约118万股，减持计划时间区间已届满

Core Viewpoint - Weisi Medical announced a significant share reduction by its shareholder Zhida Venture Capital, which may impact the company's stock performance and investor sentiment [1] Group 1: Shareholder Activity - Zhida Venture Capital reduced its holdings in Weisi Medical by approximately 960,000 shares through centralized bidding, accounting for 0.9983% of the company's total share capital [1] - Additionally, Zhida Venture Capital sold about 220,000 shares via block trading, representing 0.2305% of the total share capital [1] - The reduction period for this shareholding plan spanned from August 14, 2025, to November 11, 2025, and has now concluded [1] Group 2: Financial Performance - For the year 2024, Weisi Medical's revenue composition is as follows: medical devices accounted for 95.03%, other businesses for 3.79%, and additional services for 1.18% [1] - As of the announcement date, Weisi Medical's market capitalization stands at 4.6 billion yuan [1]